Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Jörg Senn

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Lancet. Oncology|June 18, 2002
Insulin-like growth factors and cancerGregor Fürstenberger, Hans-Jörg Senn
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
The antihormonal preventive therapy of breast cancer and prostate cancerHans-Jörg Senn, Rudolf Morant, Florian Otto
Breast (Edinburgh, Scotland)|July 7, 2005
Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancerGregor Fürstenberger, Eva Senn, Rudolf Morant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2003
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancerAron Goldhirsch, William C Wood, Richard D Gelber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2006
Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancerPatrick Urban, Vincent Vuaroqueaux, Martin Labuhn, et al.
The Lancet. Oncology|May 5, 2009
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementJack Cuzick, Florian Otto, John A Baron, et al.
Archives of Gynecology and Obstetrics|November 6, 2013
Breakthroughs in research and treatment of early breast cancer: an overview of the last three decadesManfred Kaufmann, Gunter von Minckwitz, Jonas Bergh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendationsManfred Kaufmann, Gunter von Minckwitz, Roy Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Breast cancer in pregnancy: recommendations of an international consensus meetingFrédéric Amant, Sarah Deckers, Kristel Van Calsteren, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Lancet. Oncology|June 18, 2002
Insulin-like growth factors and cancerGregor Fürstenberger, Hans-Jörg Senn
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
The antihormonal preventive therapy of breast cancer and prostate cancerHans-Jörg Senn, Rudolf Morant, Florian Otto
Breast (Edinburgh, Scotland)|July 7, 2005
Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancerGregor Fürstenberger, Eva Senn, Rudolf Morant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2003
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancerAron Goldhirsch, William C Wood, Richard D Gelber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2006
Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancerPatrick Urban, Vincent Vuaroqueaux, Martin Labuhn, et al.
The Lancet. Oncology|May 5, 2009
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementJack Cuzick, Florian Otto, John A Baron, et al.
Archives of Gynecology and Obstetrics|November 6, 2013
Breakthroughs in research and treatment of early breast cancer: an overview of the last three decadesManfred Kaufmann, Gunter von Minckwitz, Jonas Bergh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendationsManfred Kaufmann, Gunter von Minckwitz, Roy Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Breast cancer in pregnancy: recommendations of an international consensus meetingFrédéric Amant, Sarah Deckers, Kristel Van Calsteren, et al.
Pageof 1